The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hyoscine-Global Market Insights and Sales Trends 2025
Synopsis
Hyoscine, also referred as scopolamine, is utilized as a medicine to treat motion sickness, gastrointestinal spasms, vomiting, and postoperative nausea. In addition, it is utilized sometimes before surgery to decrease saliva. Hyoscine belongs to antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.
The global Hyoscine market size is expected to reach US$ 617.1 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Hyoscine in various end use industries. The expanding demands from the Oral, Injections and Patches,, are propelling Hyoscine market. Hyoscine Butylbromide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hyoscine Hydrobromide segment is estimated at % CAGR for the next seven-year period.
The increased incidence of motion sicknesses such as nausea and vomiting further led to the adoption of hyoscine medicines. Additionally, the market's growth is aided by increased research in the field of Hyoscine. For instance, an article published on April 2022 by BMC Journal showed that pre-treatment with intravenous hyoscine butyl-bromide (HBB) is a risk-free method for both the mother and the child in cesarean section patients undergoing spinal anesthesia to lower the risk of severe intraoperative bradycardia. Furthermore, the increase in travel worldwide is likely to boost the hyoscine market since motion sickness is mainly treated with hyoscine. For instance, as per the June 2022 report from UNWTO, the latest World Tourism Barometer showed an increase of 182% for international tourism in the first three months of 2022 compared to the previous year.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hyoscine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hyoscine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hyoscine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hyoscine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hyoscine covered in this report include Alchem International Ltd., Alkaloids Corporation, Baxter International Inc., Caleb Pharmaceuticals, Inc., Centroflora Cms S. R.L., GlaxoSmithKline Plc, Guangzhou Hanfang Pharmaceutical Co., Ltd., Myungmoon Pharma Co., Ltd. and Novartis International AG, etc.
The global Hyoscine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alchem International Ltd.
Alkaloids Corporation
Baxter International Inc.
Caleb Pharmaceuticals, Inc.
Centroflora Cms S. R.L.
GlaxoSmithKline Plc
Guangzhou Hanfang Pharmaceutical Co., Ltd.
Myungmoon Pharma Co., Ltd.
Novartis International AG
Perrigo Company Plc
Boehringer-Ingelheim
Linnea
C2 PHARMA
Global Hyoscine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hyoscine market, Segment by Type:
Hyoscine Butylbromide
Hyoscine Hydrobromide
Global Hyoscine market, by Application
Oral
Injections
Patches
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hyoscine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hyoscine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hyoscine, also referred as scopolamine, is utilized as a medicine to treat motion sickness, gastrointestinal spasms, vomiting, and postoperative nausea. In addition, it is utilized sometimes before surgery to decrease saliva. Hyoscine belongs to antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.
The global Hyoscine market size is expected to reach US$ 617.1 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Hyoscine in various end use industries. The expanding demands from the Oral, Injections and Patches,, are propelling Hyoscine market. Hyoscine Butylbromide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hyoscine Hydrobromide segment is estimated at % CAGR for the next seven-year period.
The increased incidence of motion sicknesses such as nausea and vomiting further led to the adoption of hyoscine medicines. Additionally, the market's growth is aided by increased research in the field of Hyoscine. For instance, an article published on April 2022 by BMC Journal showed that pre-treatment with intravenous hyoscine butyl-bromide (HBB) is a risk-free method for both the mother and the child in cesarean section patients undergoing spinal anesthesia to lower the risk of severe intraoperative bradycardia. Furthermore, the increase in travel worldwide is likely to boost the hyoscine market since motion sickness is mainly treated with hyoscine. For instance, as per the June 2022 report from UNWTO, the latest World Tourism Barometer showed an increase of 182% for international tourism in the first three months of 2022 compared to the previous year.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hyoscine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hyoscine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hyoscine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hyoscine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hyoscine covered in this report include Alchem International Ltd., Alkaloids Corporation, Baxter International Inc., Caleb Pharmaceuticals, Inc., Centroflora Cms S. R.L., GlaxoSmithKline Plc, Guangzhou Hanfang Pharmaceutical Co., Ltd., Myungmoon Pharma Co., Ltd. and Novartis International AG, etc.
The global Hyoscine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alchem International Ltd.
Alkaloids Corporation
Baxter International Inc.
Caleb Pharmaceuticals, Inc.
Centroflora Cms S. R.L.
GlaxoSmithKline Plc
Guangzhou Hanfang Pharmaceutical Co., Ltd.
Myungmoon Pharma Co., Ltd.
Novartis International AG
Perrigo Company Plc
Boehringer-Ingelheim
Linnea
C2 PHARMA
Global Hyoscine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hyoscine market, Segment by Type:
Hyoscine Butylbromide
Hyoscine Hydrobromide
Global Hyoscine market, by Application
Oral
Injections
Patches
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hyoscine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hyoscine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hyoscine Market Overview
1.1 Hyoscine Product Overview
1.2 Hyoscine Market Segment by Type
1.2.1 Hyoscine Butylbromide
1.2.2 Hyoscine Hydrobromide
1.3 Global Hyoscine Market Size by Type
1.3.1 Global Hyoscine Market Size Overview by Type (2018-2029)
1.3.2 Global Hyoscine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hyoscine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hyoscine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hyoscine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hyoscine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hyoscine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hyoscine Sales Breakdown by Type (2018-2023)
2 Global Hyoscine Market Competition by Company
2.1 Global Top Players by Hyoscine Sales (2018-2023)
2.2 Global Top Players by Hyoscine Revenue (2018-2023)
2.3 Global Top Players by Hyoscine Price (2018-2023)
2.4 Global Top Manufacturers Hyoscine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hyoscine Market Competitive Situation and Trends
2.5.1 Hyoscine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hyoscine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hyoscine as of 2022)
2.7 Date of Key Manufacturers Enter into Hyoscine Market
2.8 Key Manufacturers Hyoscine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hyoscine Status and Outlook by Region
3.1 Global Hyoscine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hyoscine Historic Market Size by Region
3.2.1 Global Hyoscine Sales in Volume by Region (2018-2023)
3.2.2 Global Hyoscine Sales in Value by Region (2018-2023)
3.2.3 Global Hyoscine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hyoscine Forecasted Market Size by Region
3.3.1 Global Hyoscine Sales in Volume by Region (2024-2029)
3.3.2 Global Hyoscine Sales in Value by Region (2024-2029)
3.3.3 Global Hyoscine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hyoscine by Application
4.1 Hyoscine Market Segment by Application
4.1.1 Oral
4.1.2 Injections
4.1.3 Patches
4.2 Global Hyoscine Market Size by Application
4.2.1 Global Hyoscine Market Size Overview by Application (2018-2029)
4.2.2 Global Hyoscine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hyoscine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hyoscine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hyoscine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hyoscine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hyoscine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hyoscine Sales Breakdown by Application (2018-2023)
5 North America Hyoscine by Country
5.1 North America Hyoscine Historic Market Size by Country
5.1.1 North America Hyoscine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hyoscine Sales in Volume by Country (2018-2023)
5.1.3 North America Hyoscine Sales in Value by Country (2018-2023)
5.2 North America Hyoscine Forecasted Market Size by Country
5.2.1 North America Hyoscine Sales in Volume by Country (2024-2029)
5.2.2 North America Hyoscine Sales in Value by Country (2024-2029)
6 Europe Hyoscine by Country
6.1 Europe Hyoscine Historic Market Size by Country
6.1.1 Europe Hyoscine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hyoscine Sales in Volume by Country (2018-2023)
6.1.3 Europe Hyoscine Sales in Value by Country (2018-2023)
6.2 Europe Hyoscine Forecasted Market Size by Country
6.2.1 Europe Hyoscine Sales in Volume by Country (2024-2029)
6.2.2 Europe Hyoscine Sales in Value by Country (2024-2029)
7 Asia-Pacific Hyoscine by Region
7.1 Asia-Pacific Hyoscine Historic Market Size by Region
7.1.1 Asia-Pacific Hyoscine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hyoscine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hyoscine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hyoscine Forecasted Market Size by Region
7.2.1 Asia-Pacific Hyoscine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hyoscine Sales in Value by Region (2024-2029)
8 Latin America Hyoscine by Country
8.1 Latin America Hyoscine Historic Market Size by Country
8.1.1 Latin America Hyoscine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hyoscine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hyoscine Sales in Value by Country (2018-2023)
8.2 Latin America Hyoscine Forecasted Market Size by Country
8.2.1 Latin America Hyoscine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hyoscine Sales in Value by Country (2024-2029)
9 Middle East and Africa Hyoscine by Country
9.1 Middle East and Africa Hyoscine Historic Market Size by Country
9.1.1 Middle East and Africa Hyoscine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hyoscine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hyoscine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hyoscine Forecasted Market Size by Country
9.2.1 Middle East and Africa Hyoscine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hyoscine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Alchem International Ltd.
10.1.1 Alchem International Ltd. Company Information
10.1.2 Alchem International Ltd. Introduction and Business Overview
10.1.3 Alchem International Ltd. Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Alchem International Ltd. Hyoscine Products Offered
10.1.5 Alchem International Ltd. Recent Development
10.2 Alkaloids Corporation
10.2.1 Alkaloids Corporation Company Information
10.2.2 Alkaloids Corporation Introduction and Business Overview
10.2.3 Alkaloids Corporation Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alkaloids Corporation Hyoscine Products Offered
10.2.5 Alkaloids Corporation Recent Development
10.3 Baxter International Inc.
10.3.1 Baxter International Inc. Company Information
10.3.2 Baxter International Inc. Introduction and Business Overview
10.3.3 Baxter International Inc. Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Baxter International Inc. Hyoscine Products Offered
10.3.5 Baxter International Inc. Recent Development
10.4 Caleb Pharmaceuticals, Inc.
10.4.1 Caleb Pharmaceuticals, Inc. Company Information
10.4.2 Caleb Pharmaceuticals, Inc. Introduction and Business Overview
10.4.3 Caleb Pharmaceuticals, Inc. Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Caleb Pharmaceuticals, Inc. Hyoscine Products Offered
10.4.5 Caleb Pharmaceuticals, Inc. Recent Development
10.5 Centroflora Cms S. R.L.
10.5.1 Centroflora Cms S. R.L. Company Information
10.5.2 Centroflora Cms S. R.L. Introduction and Business Overview
10.5.3 Centroflora Cms S. R.L. Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Centroflora Cms S. R.L. Hyoscine Products Offered
10.5.5 Centroflora Cms S. R.L. Recent Development
10.6 GlaxoSmithKline Plc
10.6.1 GlaxoSmithKline Plc Company Information
10.6.2 GlaxoSmithKline Plc Introduction and Business Overview
10.6.3 GlaxoSmithKline Plc Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Plc Hyoscine Products Offered
10.6.5 GlaxoSmithKline Plc Recent Development
10.7 Guangzhou Hanfang Pharmaceutical Co., Ltd.
10.7.1 Guangzhou Hanfang Pharmaceutical Co., Ltd. Company Information
10.7.2 Guangzhou Hanfang Pharmaceutical Co., Ltd. Introduction and Business Overview
10.7.3 Guangzhou Hanfang Pharmaceutical Co., Ltd. Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Guangzhou Hanfang Pharmaceutical Co., Ltd. Hyoscine Products Offered
10.7.5 Guangzhou Hanfang Pharmaceutical Co., Ltd. Recent Development
10.8 Myungmoon Pharma Co., Ltd.
10.8.1 Myungmoon Pharma Co., Ltd. Company Information
10.8.2 Myungmoon Pharma Co., Ltd. Introduction and Business Overview
10.8.3 Myungmoon Pharma Co., Ltd. Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Myungmoon Pharma Co., Ltd. Hyoscine Products Offered
10.8.5 Myungmoon Pharma Co., Ltd. Recent Development
10.9 Novartis International AG
10.9.1 Novartis International AG Company Information
10.9.2 Novartis International AG Introduction and Business Overview
10.9.3 Novartis International AG Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novartis International AG Hyoscine Products Offered
10.9.5 Novartis International AG Recent Development
10.10 Perrigo Company Plc
10.10.1 Perrigo Company Plc Company Information
10.10.2 Perrigo Company Plc Introduction and Business Overview
10.10.3 Perrigo Company Plc Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Perrigo Company Plc Hyoscine Products Offered
10.10.5 Perrigo Company Plc Recent Development
10.11 Boehringer-Ingelheim
10.11.1 Boehringer-Ingelheim Company Information
10.11.2 Boehringer-Ingelheim Introduction and Business Overview
10.11.3 Boehringer-Ingelheim Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Boehringer-Ingelheim Hyoscine Products Offered
10.11.5 Boehringer-Ingelheim Recent Development
10.12 Linnea
10.12.1 Linnea Company Information
10.12.2 Linnea Introduction and Business Overview
10.12.3 Linnea Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Linnea Hyoscine Products Offered
10.12.5 Linnea Recent Development
10.13 C2 PHARMA
10.13.1 C2 PHARMA Company Information
10.13.2 C2 PHARMA Introduction and Business Overview
10.13.3 C2 PHARMA Hyoscine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 C2 PHARMA Hyoscine Products Offered
10.13.5 C2 PHARMA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hyoscine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hyoscine Industrial Chain Analysis
11.4 Hyoscine Market Dynamics
11.4.1 Hyoscine Industry Trends
11.4.2 Hyoscine Market Drivers
11.4.3 Hyoscine Market Challenges
11.4.4 Hyoscine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hyoscine Distributors
12.3 Hyoscine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
